Long-term L-DOPA therapy: challenges to our understanding and for the care of people with Parkinson's disease

Exp Neurol. 2003 Nov;184(1):9-13. doi: 10.1016/s0014-4886(03)00304-2.
No abstract available

Publication types

  • Comment
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Antiparkinson Agents / therapeutic use*
  • Disease Progression
  • Dopamine / physiology
  • Dyskinesias / drug therapy
  • Dyskinesias / physiopathology
  • Dystonia / drug therapy
  • Dystonia / physiopathology
  • Humans
  • Levodopa / therapeutic use*
  • Long-Term Care
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / physiopathology

Substances

  • Antiparkinson Agents
  • Levodopa
  • Dopamine